CIP
EBS icon

Convergence Investment Partners’s Emergent Biosolutions EBS Stock Holding History

Convergence Investment Partners’s Portfolio EBS Stock Details EBS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-3,701
Closed -$187K – 321
2019
Q1 		$187K Sell
3,701
-3,807
-51% -$225K 0.04% 281
2018
Q4 		$445K Sell
7,508
-1,185
-14% -$76.4K 0.1% 198
2018
Q3 		$572K Sell
8,693
-10,105
-54% -$590K 0.12% 202
2018
Q2 		$949K Sell
18,798
-62,982
-77% -$3.28M 0.13% 203
2018
Q1 		$4.31M Sell
81,780
-5,533
-6% -$276K 0.56% 45
2017
Q4 		$4.06M Buy
87,313
+36,247
+71% +$1.53M 0.54% 50
2017
Q3 		$2.07M Buy
+51,066
New +$1.85M 0.29% 134
2017
Q1 		– Sell
-37,389
Closed -$1.23M – 345
2016
Q4 		$1.23M Sell
37,389
-11,778
-24% -$353K 0.17% 239
2016
Q3 		$1.55M Buy
+49,167
New +$1.43M 0.23% 168
2016
Q2 		– Sell
-40,818
Closed -$1.48M – 324
2016
Q1 		$1.48M Sell
40,818
-5,320
-12% -$188K 0.18% 199
2015
Q4 		$1.85M Sell
46,138
-4,770
-9% -$166K 0.21% 175
2015
Q3 		$1.45M Sell
50,908
-11,310
-18% -$373K 0.17% 202
2015
Q2 		$2.05M Buy
+62,218
New +$1.93M 0.2% 168
2014
Q4 		– Sell
-58,672
Closed -$1.25M – 380
2014
Q3 		$1.25M Buy
58,672
+17,728
+43% +$406K 0.17% 190
2014
Q2 		$920K Sell
40,944
-9,500
-19% -$221K 0.12% 253
2014
Q1 		$1.27M Buy
50,444
+20,736
+70% +$524K 0.19% 162
2013
Q4 		$683K Buy
+29,708
New +$619K 0.11% 220

Other funds holding EBS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
SCM
Snyder Capital Management San Francisco, California $5.16B AUM 26.72% 1-Year Est. Return

Convergence Investment Partners's EBS Position: Q2 2019 in Review

Convergence Investment Partners sold out of Emergent Biosolutions (EBS) in Q2 2019, closing a stake of 3,701 shares — an estimated $187K sold.

Convergence Investment Partners first reported a position in EBS in Q4 2013 and held it in 17 quarters. The position peaked at $4.31M in Q1 2018. 233 funds tracked by Wall St. Rank hold EBS as of Q2 2019.

  • Convergence Investment Partners reported no remaining Emergent Biosolutions position as of Q2 2019 after selling out during the quarter.
  • Convergence Investment Partners sold 3,701 Emergent Biosolutions shares in Q2 2019, an estimated $187K.
  • Convergence Investment Partners first reported a position in Emergent Biosolutions in Q4 2013 and held it in 17 quarters.
  • Convergence Investment Partners's Emergent Biosolutions position peaked at $4.31M in Q1 2018.
  • 233 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q2 2019.

Based on Convergence Investment Partners's 13F filing for Q2 2019, filed 23 Jul 2019.